Echo for DCMP at Chughtai Lab

Echo for DCMP at Chughtai Lab

An Echocardiogram (Echo) for Dilated Cardiomyopathy (DCMP) is a specialized, non-invasive cardiac imaging procedure designed to evaluate the structure, function, and hemodynamics of the heart. Dilated Cardiomyopathy is a progressive myocardial disease characterized by ventricular chamber enlargement and systolic dysfunction, primarily affecting the left ventricle. At Chughtai Lab, this diagnostic investigation is performed using state-of-the-art transthoracic echocardiography (TTE) systems equipped with high-resolution 2D imaging, M-mode analysis, Color Flow Doppler, Continuous Wave Doppler, and Pulsed Wave Doppler capabilities. By utilizing high-frequency sound waves, this test allows consultant cardiologists and sonologists to visualize the beating heart in real-time without exposing the patient to ionizing radiation.

The primary clinical objective of an Echo for DCMP is to assess the degree of chamber dilation and quantify the reduction in myocardial contractility. The examination evaluates all four cardiac chambers (left ventricle, right ventricle, left atrium, and right atrium), the four primary cardiac valves (mitral, aortic, tricuspid, and pulmonary), the myocardium, and the surrounding pericardial space. This comprehensive assessment provides invaluable diagnostic data, allowing clinicians to differentiate DCMP from other forms of heart disease, such as hypertrophic or restrictive cardiomyopathy, ischemic heart disease, and valvular heart disorders.

The clinical utility of this test extends beyond initial diagnosis. It is crucial for risk stratification, guiding therapeutic interventions (such as guideline-directed medical therapy, device implantation like ICDs or CRTs, or surgical options), and monitoring the patient’s longitudinal response to treatment. By providing precise measurements of the left ventricular ejection fraction (LVEF), end-diastolic and end-systolic volumes, and valvular regurgitation severity, the Echo for DCMP at Chughtai Lab serves as the cornerstone of clinical decision-making for patients presenting with signs and symptoms of congestive heart failure.

Clinical Procedure: What to Expect

Patient Preparation

Preparing for a standard transthoracic echocardiogram for Dilated Cardiomyopathy is straightforward, as the procedure is entirely non-invasive. Patients should observe the following guidelines to ensure a smooth and efficient diagnostic session:

• No Fasting Required: Unlike certain abdominal scans or blood tests, you do not need to fast before an echocardiogram. You may eat, drink, and take your prescribed cardiovascular medications as usual, unless specifically instructed otherwise by your referring physician.
• Wear Comfortable Clothing: It is highly recommended to wear loose-fitting, two-piece clothing. You will be asked to remove your upper garments and wear a clinical gown to allow the sonographer easy access to your chest area.
• Avoid Skin Creams and Lotions: Do not apply heavy moisturizers, body oils, or chest creams on the day of the test. These substances can interfere with the acoustic gel and prevent the ultrasound transducer from making optimal contact with your skin, potentially degrading image quality.
• Bring Medical Records: Always bring your previous echocardiogram reports, electrocardiograms (ECGs), chest X-rays, and a complete list of your current medications. Comparing current findings with historical data is vital for assessing the progression or regression of Dilated Cardiomyopathy.
• Arrive Early: Plan to arrive at the Chughtai Lab diagnostic center approximately 15 minutes before your scheduled appointment to complete any necessary registration paperwork.

During the Procedure

The echocardiogram is performed in a dedicated, dimly lit ultrasound room to optimize the visualization of the monitor screens. The clinical workflow proceeds as follows:

• Patient Positioning: You will be asked to lie down on an examination table, typically on your left side (left lateral decubitus position). This position helps bring the heart closer to the anterior chest wall, providing clearer acoustic windows.
• Electrode Placement: Small, adhesive ECG electrodes will be attached to your chest to monitor your heart rate and rhythm continuously during the scan. This allows the ultrasound system to synchronize the imaging frames with specific phases of the cardiac cycle (systole and diastole).
• Acoustic Gel Application: A warm, water-soluble acoustic gel is applied to your chest. This gel eliminates air pockets between the skin and the transducer, facilitating the seamless transmission and reception of high-frequency sound waves.
• Transducer Manipulation: The cardiac sonographer or cardiologist will gently press the ultrasound transducer against various areas of your chest (parasternal, apical, subcostal, and suprasternal views). You may feel mild pressure, but the procedure is entirely painless.
• Doppler Evaluation: During the scan, you will hear audible whooshing or pulsing sounds. This is the Doppler audio, which represents the velocity and direction of blood flowing through your heart valves and chambers.
• Duration and Safety: The entire examination typically takes between 30 and 45 minutes. Because the test uses sound waves rather than radiation, it is completely safe, carries no side effects, and can be performed repeatedly even during pregnancy. Once completed, the gel is wiped off, and you can immediately resume your normal daily activities.

When is an Echo for DCMP Performed?

1. Evaluation of Unexplained Shortness of Breath and Fatigue

Dyspnea (shortness of breath) during exertion, orthopnea (difficulty breathing when lying flat), and profound fatigue are hallmark clinical manifestations of heart failure associated with Dilated Cardiomyopathy. When a patient presents with these symptoms, physicians request an Echo for DCMP to evaluate whether the underlying cause is a weakened cardiac muscle. The test determines if the heart’s pumping capacity is compromised, helping clinicians differentiate cardiac-induced dyspnea from pulmonary conditions like asthma or chronic obstructive pulmonary disease (COPD).

2. Assessment of Left Ventricular Systolic Dysfunction

Systolic dysfunction, characterized by a reduced ability of the left ventricle to contract and eject blood into the systemic circulation, is the physiological defining feature of DCMP. An echocardiogram is performed to quantitatively measure the Left Ventricular Ejection Fraction (LVEF). A normal LVEF ranges between 55% and 70%, whereas in patients with DCMP, it is typically reduced to below 45%, and often below 35% in severe cases. This measurement is critical for initiating guideline-directed medical therapies, such as beta-blockers, ACE inhibitors, and mineralocorticoid receptor antagonists.

3. Monitoring Progression of Dilated Cardiomyopathy

For patients with an established diagnosis of DCMP, regular echocardiographic monitoring is essential to track the progression of the disease and evaluate the efficacy of therapeutic interventions. Physicians utilize serial Echo scans to observe changes in ventricular volumes, assess improvements in ejection fraction, and monitor for potential complications such as worsening valvular regurgitation or the development of intracardiac thrombi. These follow-up assessments guide decisions regarding medication titration or the necessity of advanced device therapies.

4. Investigating Cardiomegaly on Chest X-Ray

An enlarged cardiac silhouette (cardiomegaly) detected on a routine chest X-ray is a common incidental finding that warrants immediate diagnostic investigation. Because a chest X-ray only provides a two-dimensional shadow of the heart, it cannot determine whether the enlargement is due to muscular hypertrophy, chamber dilation, or pericardial effusion. An Echo for DCMP is performed to definitively evaluate the internal chamber dimensions, confirming whether true ventricular dilation and associated systolic dysfunction are present.

5. Screening for Familial Dilated Cardiomyopathy

Approximately 20% to 35% of cases of non-ischemic Dilated Cardiomyopathy have a genetic or familial etiology. Consequently, clinical guidelines recommend screening first-degree relatives of patients diagnosed with idiopathic DCMP. An echocardiogram serves as the primary screening tool to detect early, asymptomatic structural changes, such as mild left ventricular dilation or borderline systolic dysfunction, enabling early clinical surveillance and timely therapeutic intervention if necessary.

What Does an Echo for DCMP Detect?

An Echo for DCMP provides a detailed anatomical and functional assessment of the heart, detecting a wide range of pathological changes:

• Left Ventricular Dilation: Increased left ventricular end-diastolic and end-systolic dimensions exceeding normal reference ranges adjusted for body surface area.
• Reduced Ejection Fraction (LVEF): Quantitative reduction in the percentage of blood pumped out of the left ventricle with each contraction.
• Global Hypokinesia: Generalized, uniform reduction in the contraction and thickening of the myocardial walls during systole.
• Left Atrial Enlargement: Dilation of the left atrium resulting from chronically elevated left ventricular filling pressures.
• Functional Mitral Regurgitation: Backward leakage of blood through the mitral valve caused by annular dilation and tethering of the valve leaflets.
• Right Ventricular Dilation and Dysfunction: Enlargement and reduced pumping capacity of the right ventricle, often indicating advanced disease.
• Tricuspid Regurgitation: Leakage of the tricuspid valve, frequently secondary to right ventricular dilation or pulmonary hypertension.
• Diastolic Dysfunction: Impaired relaxation and filling of the left ventricle during the diastolic phase of the cardiac cycle.
• Intracardiac Thrombus: Blood clots, typically located in the left ventricular apex, forming due to severe blood stasis (stagnation) in a poorly contracting chamber.
• Spontaneous Echocardiographic Contrast: A swirling, smoke-like appearance within the cardiac chambers indicating slow-moving blood flow and high thromboembolic risk.
• Reduced Stroke Volume: A decrease in the actual volume of blood ejected by the left ventricle per beat.
• Decreased Cardiac Output: A reduction in the total volume of blood pumped by the heart per minute.
• Increased Mitral Valve E-Point Septal Separation (EPSS): An increased distance between the anterior mitral valve leaflet and the interventricular septum on M-mode, indicating reduced LV function.
• B-Notch on Mitral Valve M-Mode: An abnormal notch on the mitral valve closure curve indicating elevated left ventricular end-diastolic pressure.
• Decreased Aortic Root Excursion: Reduced forward and backward movement of the aortic root, reflecting low stroke volume.
• Dilated Inferior Vena Cava (IVC): Enlargement of the IVC with reduced inspiratory collapse, indicating elevated right atrial pressure.
• Pulmonary Artery Hypertension: Elevated systolic pressure within the pulmonary vasculature, estimated from the tricuspid regurgitant jet velocity.
• Eccentric Left Ventricular Hypertrophy: An increase in left ventricular mass with a normal relative wall thickness, characteristic of volume overload.
• Pericardial Effusion: An abnormal accumulation of fluid in the pericardial sac surrounding the heart, occasionally seen in advanced heart failure.
• Abnormal Global Longitudinal Strain (GLS): Reduced myocardial deformation parameters, detecting subclinical systolic dysfunction even before the ejection fraction drops.

Turnaround Time and Report Access at Chughtai Lab

At Chughtai Lab, we understand that timely diagnostic results are critical for patient care and clinical peace of mind. The Echocardiogram for DCMP is performed by highly trained medical professionals, and the preliminary findings are reviewed by consultant cardiologists or radiologists. The finalized, comprehensive report—complete with high-resolution cardiac images, quantitative measurements, and expert clinical interpretations—is typically ready within 24 to 48 hours of the procedure.

Patients can easily access their diagnostic reports through multiple convenient channels. Chughtai Lab provides a secure online portal on their official website, allowing patients to download and print their reports from the comfort of their homes. Additionally, the Chughtai Lab Mobile App offers instant notifications and digital access to all historical and current laboratory and imaging reports. For patients who prefer physical copies, reports can be collected directly from the diagnostic center where the test was performed, or delivered via WhatsApp for rapid sharing with referring physicians.

Echo for DCMP Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Left Ventricular Internal Diameter (LVIDd)	Male: 42.0 – 58.4 mm Female: 37.8 – 52.2 mm	Significantly increased (dilated), often exceeding 60 mm, indicating chamber enlargement.
Left Ventricular Ejection Fraction (LVEF)	55% – 70%	Reduced (mild: 41-54%, moderate: 30-40%, severe: <30%), indicating systolic dysfunction.
Myocardial Wall Motion	Normal synchronous contraction and systolic thickening of all segments.	Global hypokinesia (diffuse, uniform reduction in contraction) or localized akinesia.
Mitral Valve Function	Normal leaflet coaptation, no significant regurgitation.	Functional mitral regurgitation (MR) due to annular dilation and leaflet tethering.
Left Atrial Volume Index (LAVI)	16 – 34 mL/m²	Increased (dilated), indicating chronic volume and pressure overload from the left ventricle.
Right Ventricular (RV) Function	Normal size and contractility (TAPSE > 17 mm).	RV dilation and reduced systolic function (TAPSE < 17 mm) in advanced stages of DCMP.
Pericardial Space	No fluid or physiological trace fluid only.	Mild to moderate pericardial effusion, reflecting advanced congestive heart failure.
Diastolic Function (E/A Ratio)	0.8 to 2.0 (age-dependent)	Abnormal patterns (impaired relaxation or restrictive filling) indicating diastolic dysfunction.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Echo for DCMP?

• Experienced Healthcare Professionals: Our cardiac imaging department is staffed by highly qualified cardiac sonographers and consultant cardiologists with extensive experience in diagnosing complex cardiomyopathies.
• Patient-Focused Care: At Chughtai Lab, we prioritize patient comfort, safety, and dignity, ensuring a supportive environment throughout the diagnostic procedure.
• Quality Diagnostic Services: We adhere to strict international quality control guidelines, ensuring that every echocardiographic measurement is highly accurate and reproducible.
• Professional Reporting: Our reports provide detailed quantitative data, including chamber volumes, ejection fraction, and valvular hemodynamics, essential for clinical decision-making.
• Modern Diagnostic Approach: We utilize advanced ultrasound systems equipped with state-of-the-art Doppler and tissue imaging technologies to capture high-definition cardiac structures.
• Comfortable Environment: Our diagnostic centers are designed to offer a clean, hygienic, and relaxing atmosphere, minimizing patient anxiety during clinical examinations.
• Convenient Location: With an extensive network of diagnostic centers across Pakistan, patients can easily access high-quality cardiac imaging services close to home.
• Commitment to Accurate Diagnosis: Chughtai Lab is dedicated to delivering precise, evidence-based diagnostic results that clinicians nationwide trust for patient management.